Literature DB >> 20562460

POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases.

S Isose1, S Misawa, K Kanai, K Shibuya, Y Sekiguchi, S Nasu, Y Fujimaki, Y Noto, C Nakaseko, S Kuwabara.   

Abstract

POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome is a rare cause of demyelinating neuropathy with monoclonal plasma cell proliferation, and POEMS neuropathy is usually chronically progressive. Herein, the authors report a 34-year-old woman with POEMS syndrome presenting as acute polyneuropathy. Within 2 weeks of disease onset, she became unable to walk with electrodiagnostic features of demyelination and was initially diagnosed as having Guillan-Barré syndrome. Other systemic features (oedema and skin changes) developed later, and an elevated serum level of vascular endothelial growth factor led to the diagnosis of POEMS syndrome. She received high-dose chemotherapy with autologous peripheral blood stem cell transplantation, resulting in good recovery. The authors also reviewed patterns and speed of progression of neuropathy in the 30 patients with POEMS syndrome; 22 (73%) of them were unable to walk independently with the median period of 9.5 months from POEMS onset (range 0.5-51 months). Whereas the speed of neuropathy progression varies considerably among patients, some POEMS patients can show acute or subacute polyneuropathy. The early diagnosis and treatment could result in rapid improvement as shown in the present patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562460     DOI: 10.1136/jnnp.2010.205369

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

Review 1.  Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.

Authors:  Satoshi Kuwabara; Angela Dispenzieri; Kimiyoshi Arimura; Sonoko Misawa; Chiaki Nakaseko
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

2.  Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  Kanako Katayama; Sonoko Misawa; Yasunori Sato; Gen Sobue; Ichiro Yabe; Osamu Watanabe; Masatoyo Nishizawa; Susumu Kusunoki; Seiji Kikuchi; Ichiro Nakashima; Shu-Ichi Ikeda; Nobuo Kohara; Takashi Kanda; Jun-Ichi Kira; Hideki Hanaoka; Satoshi Kuwabara
Journal:  BMJ Open       Date:  2015-01-08       Impact factor: 2.692

3.  Rapidly Progressive Polyneuropathy in a Patient With Monoclonal Gammopathy: A Case Report of POEMS Syndrome and Beyond.

Authors:  Chen Wang; Yu-Zhou Guan; Qian-Qian Cai; Wei Su; Dao-Bin Zhou; Jian Li
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Asymmetric optic disc edema in a young patient with POEMS: A rare presentation of a rare disease.

Authors:  Hana Mahallati; James Kirkland Roberts; Amer Assal; Divaya Bhutani; David C Park; Golnaz Moazami
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-16

5.  Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.

Authors:  S Misawa; Y Sato; K Katayama; H Hanaoka; S Sawai; M Beppu; F Nomura; K Shibuya; Y Sekiguchi; Y Iwai; K Watanabe; H Amino; C Ohwada; M Takeuchi; E Sakaida; C Nakaseko; S Kuwabara
Journal:  BMJ Open       Date:  2015-11-11       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.